The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Iakushina T.I.

Belova Iu.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Cases of pregnancy in patients with aggressive multiple sclerosis treated with natalizumab

Authors:

Iakushina T.I., Belova Iu.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(2‑2): 94‑97

DOI: 10.17116/jnevro20191192294

Views: 1344

Downloaded: 19

Download PDF (RU)
Contact the author
Table of contents

CASES OF PREGNANCY IN PATIENTS WITH AGGRESSIVE MULTIPLE SCLEROSIS TREATED WITH NATALIZUMAB
CASES OF PREGNANCY IN PATIENTS WITH AGGRESSIVE MULTIPLE SCLEROSIS TREATED WITH NATALIZUMAB

To cite this article:

Iakushina TI, Belova IuA. Cases of pregnancy in patients with aggressive multiple sclerosis treated with natalizumab. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(2‑2):94‑97. (In Russ.)
https://doi.org/10.17116/jnevro20191192294

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Close metadata
Recommended articles:
Biobanking in clinical trials invo­lving multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):7-15
The diagnostic effe­ctiveness of criteria for neuromyelitis optica spectrum diso­rders in the Russian clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):16-25
Adhe­rence to treatment in the mana­gement of patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):26-32
Opti­mal patient profile for ofatumumab treatment: analysis of Russian data from the Phase 3 study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):37-42
The effect of pregnancy on multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):43-49
A role of cere­brovascular diseases in the progression of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):53-57
Opti­cal cohe­rence tomo­graphy in the diagnosis of multiple scle­rosis. Russian Annals of Ophthalmology. 2024;(3):59-68
Questionnaires for arm function asse­ssment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):36-42
Features of primary forms of headache in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):70-73
Neurofilament light chain: a diagnostic pote­ntial for multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):115-119

The authors consider the issues concerning planning of pregnancy in patients with multiple sclerosis receiving pathogenetic and immunomodulatory therapy and provide descriptions of cases of pregnancy in patients with aggressively multiple sclerosis occurred during the treatment with natalizumab.

Keywords:

multiple sclerosis
aggressive multiple sclerosis
multiple sclerosis and pregnancy
natalizumab

Authors:

Iakushina T.I.

Belova Iu.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

List of references:

  1. Yakushina TI, Kotov SV, Yakushin MA. Analysis of the course of pregnancy, delivery and postpartum period in women with multiple sclerosis. Al’manakh Klinicheskoi Meditsin. 2015;39:82-88. (In Russ.) https://doi.org/10.18786/2072-0505-2015-39-82-89
  2. Babenko LA, Malkova NA. Rasseyannyi skleroz: beremennost’ I terapiya preparatami, izmenyayushchimi techenie rasseyannogo skleroza. Materialy X Vserossiiskogo s’ezda nevrologov s mezhdunarodnym uchastiem; 2012. (In Russ.)
  3. Kotov SV, Yakushina TI. Rasseyannyi skleroz i beremennost’. Osobennosti techeniya beremennosti, rodov I poslerodovogo perioda u zhenshchin, stradayushchikh rasseyannym sklerozom. Rezul’taty nablyudenii za patsientami dannoi gruppy v Moskovskoi oblasti. Russian Medical Journal. 2015;12(23):720-724. (In Russ.)
  4. Shmidt TE, Yakhno NN. Rasseyannyi skleroz. Rukovodstvo dlya vrachei. 2-e izd. M.: MEDpress-inform; 2010. (In Russ.)
  5. Popova EV, Kukel TM, Muravin AI, Boyko AN, Murashko AV, Gusev EI. Pregnancy and deliveryin women with multiple sclerosis: a retrospective analysi. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2013;113(10-2):52-56. (In Russ.)
  6. Demina TN, Mailyan EF, Gyul’mamedova ID, Gyul’mamedov VA. Sovremennye vzglyady na immunologiyu gestatsionnogo protsessa. Reproduktivnoe Zdorov’e Zhenshchiny. 2003;1:18-22. (In Russ.)
  7. Dobrodeev KT, Usynin MV, Moskovskaya NB. Immunnaya sistema pri fiziologicheskom techenii beremennosti. Immunologiya. 2001;1:355. (In Russ.)
  8. Devonshire V, Duguette P, Dwosh E, Guimomd C, Sadovnick AD. The immune system and hormones: review and relevance to pregnancy and contraception in women with MS. Int MSJ. 2003;10(2):45-50.
  9. Gilmore W, Arias M, Stroud N, Stek A, McCarthy KA, Correale J. Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patients. J Neurol Sci. 2004;224:69-76. https://doi.org/10.1016/j.jns.2004.06.011
  10. Voskuhl R. Sex hormones and other pregnancy-related factors with therapeutic potential in multiple sclerosis. In: Cohen D., Rudick R., eds. Multiple Sclerosis Therapeutics. London: Martin Dunitz Ltd; 2003. https://doi.org/10.1017/cbo9781139023986.046
  11. Kotov SV, Yakushina TI, Lizhdvoi VYu. Long-term comparative studying efficiency of drugs that change the course of multiple sclerosise. Al’manakh Klinicheskoi Meditsin. 2011;25:37-40. (In Russ.)
  12. Zakharova MN, Lysogorskaia EV, Trushnikova TN, Zhelnin AV. The case-report of progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(8):107-109. (In Russ.) https://doi.org/10.17116/jnevro2018118082107
  13. Haghikia A, Langer-Gould A, Rellensmann G, Haghikia A, Langer-Gould A, Rellensmann G, Schneider H, Tenenbaum T, Elias-Hamp B, Menck S, Zimmermann J, Herbstritt S, Marziniak M, Kümpfel T, Mein I, Plavina T, Gold R, Hellwig K. Natalizumab use during the third trimester of pregnancy. JAMA Neurol. 2014;71(7):891-895. https://doi.org/10.1001/jamaneurol.2014.209

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.